Induced phenotype targeted therapy

Radiation-induced apoptosis-targeted chemotherapy

Beom Suk Lee, Yong Woo Cho, Gui Chul Kim, Do Hee Lee, Chang Jin Kim, Hee Seup Kil, Dae Yoon Chi, Youngro Byun, Soon Hong Yuk, Kwang Meyung Kim, In-San Kim, Ick Chan Kwon, Sang Yoon Kim

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Tumor heterogeneity and evolutionary complexity may underlie treatment failure in spite of the development of many targeted agents. We suggest a novel strategy termed induced phenotype targeted therapy (IPTT) to simplify complicated targets because of tumor heterogeneity and overcome tumor evolutionary complexity. Methods: We designed a caspase-3 specific activatable prodrug, DEVD-S-DOX, containing doxorubicin linked to a peptide moiety (DEVD) cleavable by caspase-3 upon apoptosis. To induce apoptosis locally in the tumor, we used a gamma knife, which can irradiate a very small, defined target area. The in vivo antitumor activity of the caspase-3-specific activatable prodrug combined with radiation was investigated in C3H/HeN tumor-bearing mice (n = 5 per group) and analyzed with the Student's t test or Mann-Whitney U test. All statistical tests were two-sided. We confirmed the basic principle using a caspase-sensitive nanoprobe (Apo-NP). Results: A single exposure of radiation was able to induce apoptosis in a small, defined region of the tumor, resulting in expression of caspase-3. Caspase-3 cleaved DEVD and activated the prodrug. The released free DOX further activated DEVD-S-DOX by exerting cytotoxic effects on neighboring tumor or supporting cells, which repetitively induced the expression of caspase-3 and the activation of DEVD-S-DOX. This sequential and repetitive process propagated the induction of apoptosis. This novel therapeutic strategy showed not only high efficacy in inhibiting tumor growth (14-day tumor volume [mm<sup>3</sup>] vs radiation alone: 848.21±143.24 vs 2511.50±441.89, P <. 01) but also low toxicity to normal cells and tissues. Conclusion: Such a phenotype induction strategy represents a conceptually novel approach to overcome tumor heterogeneity and complexity as well as to substantially improve current conventional chemoradiotherapy with fewer sequelae and side effects.

Original languageEnglish
Article numberdju403
JournalJournal of the National Cancer Institute
Volume107
Issue number2
DOIs
Publication statusPublished - 2015 Feb 1

Fingerprint

Radiotherapy
Apoptosis
Phenotype
Drug Therapy
Caspase 3
Neoplasms
Prodrugs
Radiation
Chemoradiotherapy
Nonparametric Statistics
Caspases
Tumor Burden
Treatment Failure
Doxorubicin
Students
Peptides
Therapeutics
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Lee, B. S., Cho, Y. W., Kim, G. C., Lee, D. H., Kim, C. J., Kil, H. S., ... Kim, S. Y. (2015). Induced phenotype targeted therapy: Radiation-induced apoptosis-targeted chemotherapy. Journal of the National Cancer Institute, 107(2), [dju403]. https://doi.org/10.1093/jnci/dju403

Induced phenotype targeted therapy : Radiation-induced apoptosis-targeted chemotherapy. / Lee, Beom Suk; Cho, Yong Woo; Kim, Gui Chul; Lee, Do Hee; Kim, Chang Jin; Kil, Hee Seup; Chi, Dae Yoon; Byun, Youngro; Yuk, Soon Hong; Kim, Kwang Meyung; Kim, In-San; Kwon, Ick Chan; Kim, Sang Yoon.

In: Journal of the National Cancer Institute, Vol. 107, No. 2, dju403, 01.02.2015.

Research output: Contribution to journalArticle

Lee, BS, Cho, YW, Kim, GC, Lee, DH, Kim, CJ, Kil, HS, Chi, DY, Byun, Y, Yuk, SH, Kim, KM, Kim, I-S, Kwon, IC & Kim, SY 2015, 'Induced phenotype targeted therapy: Radiation-induced apoptosis-targeted chemotherapy', Journal of the National Cancer Institute, vol. 107, no. 2, dju403. https://doi.org/10.1093/jnci/dju403
Lee, Beom Suk ; Cho, Yong Woo ; Kim, Gui Chul ; Lee, Do Hee ; Kim, Chang Jin ; Kil, Hee Seup ; Chi, Dae Yoon ; Byun, Youngro ; Yuk, Soon Hong ; Kim, Kwang Meyung ; Kim, In-San ; Kwon, Ick Chan ; Kim, Sang Yoon. / Induced phenotype targeted therapy : Radiation-induced apoptosis-targeted chemotherapy. In: Journal of the National Cancer Institute. 2015 ; Vol. 107, No. 2.
@article{c3f4e2f2e5104a9e9deeaa1ff9825212,
title = "Induced phenotype targeted therapy: Radiation-induced apoptosis-targeted chemotherapy",
abstract = "Background: Tumor heterogeneity and evolutionary complexity may underlie treatment failure in spite of the development of many targeted agents. We suggest a novel strategy termed induced phenotype targeted therapy (IPTT) to simplify complicated targets because of tumor heterogeneity and overcome tumor evolutionary complexity. Methods: We designed a caspase-3 specific activatable prodrug, DEVD-S-DOX, containing doxorubicin linked to a peptide moiety (DEVD) cleavable by caspase-3 upon apoptosis. To induce apoptosis locally in the tumor, we used a gamma knife, which can irradiate a very small, defined target area. The in vivo antitumor activity of the caspase-3-specific activatable prodrug combined with radiation was investigated in C3H/HeN tumor-bearing mice (n = 5 per group) and analyzed with the Student's t test or Mann-Whitney U test. All statistical tests were two-sided. We confirmed the basic principle using a caspase-sensitive nanoprobe (Apo-NP). Results: A single exposure of radiation was able to induce apoptosis in a small, defined region of the tumor, resulting in expression of caspase-3. Caspase-3 cleaved DEVD and activated the prodrug. The released free DOX further activated DEVD-S-DOX by exerting cytotoxic effects on neighboring tumor or supporting cells, which repetitively induced the expression of caspase-3 and the activation of DEVD-S-DOX. This sequential and repetitive process propagated the induction of apoptosis. This novel therapeutic strategy showed not only high efficacy in inhibiting tumor growth (14-day tumor volume [mm3] vs radiation alone: 848.21±143.24 vs 2511.50±441.89, P <. 01) but also low toxicity to normal cells and tissues. Conclusion: Such a phenotype induction strategy represents a conceptually novel approach to overcome tumor heterogeneity and complexity as well as to substantially improve current conventional chemoradiotherapy with fewer sequelae and side effects.",
author = "Lee, {Beom Suk} and Cho, {Yong Woo} and Kim, {Gui Chul} and Lee, {Do Hee} and Kim, {Chang Jin} and Kil, {Hee Seup} and Chi, {Dae Yoon} and Youngro Byun and Yuk, {Soon Hong} and Kim, {Kwang Meyung} and In-San Kim and Kwon, {Ick Chan} and Kim, {Sang Yoon}",
year = "2015",
month = "2",
day = "1",
doi = "10.1093/jnci/dju403",
language = "English",
volume = "107",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Induced phenotype targeted therapy

T2 - Radiation-induced apoptosis-targeted chemotherapy

AU - Lee, Beom Suk

AU - Cho, Yong Woo

AU - Kim, Gui Chul

AU - Lee, Do Hee

AU - Kim, Chang Jin

AU - Kil, Hee Seup

AU - Chi, Dae Yoon

AU - Byun, Youngro

AU - Yuk, Soon Hong

AU - Kim, Kwang Meyung

AU - Kim, In-San

AU - Kwon, Ick Chan

AU - Kim, Sang Yoon

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: Tumor heterogeneity and evolutionary complexity may underlie treatment failure in spite of the development of many targeted agents. We suggest a novel strategy termed induced phenotype targeted therapy (IPTT) to simplify complicated targets because of tumor heterogeneity and overcome tumor evolutionary complexity. Methods: We designed a caspase-3 specific activatable prodrug, DEVD-S-DOX, containing doxorubicin linked to a peptide moiety (DEVD) cleavable by caspase-3 upon apoptosis. To induce apoptosis locally in the tumor, we used a gamma knife, which can irradiate a very small, defined target area. The in vivo antitumor activity of the caspase-3-specific activatable prodrug combined with radiation was investigated in C3H/HeN tumor-bearing mice (n = 5 per group) and analyzed with the Student's t test or Mann-Whitney U test. All statistical tests were two-sided. We confirmed the basic principle using a caspase-sensitive nanoprobe (Apo-NP). Results: A single exposure of radiation was able to induce apoptosis in a small, defined region of the tumor, resulting in expression of caspase-3. Caspase-3 cleaved DEVD and activated the prodrug. The released free DOX further activated DEVD-S-DOX by exerting cytotoxic effects on neighboring tumor or supporting cells, which repetitively induced the expression of caspase-3 and the activation of DEVD-S-DOX. This sequential and repetitive process propagated the induction of apoptosis. This novel therapeutic strategy showed not only high efficacy in inhibiting tumor growth (14-day tumor volume [mm3] vs radiation alone: 848.21±143.24 vs 2511.50±441.89, P <. 01) but also low toxicity to normal cells and tissues. Conclusion: Such a phenotype induction strategy represents a conceptually novel approach to overcome tumor heterogeneity and complexity as well as to substantially improve current conventional chemoradiotherapy with fewer sequelae and side effects.

AB - Background: Tumor heterogeneity and evolutionary complexity may underlie treatment failure in spite of the development of many targeted agents. We suggest a novel strategy termed induced phenotype targeted therapy (IPTT) to simplify complicated targets because of tumor heterogeneity and overcome tumor evolutionary complexity. Methods: We designed a caspase-3 specific activatable prodrug, DEVD-S-DOX, containing doxorubicin linked to a peptide moiety (DEVD) cleavable by caspase-3 upon apoptosis. To induce apoptosis locally in the tumor, we used a gamma knife, which can irradiate a very small, defined target area. The in vivo antitumor activity of the caspase-3-specific activatable prodrug combined with radiation was investigated in C3H/HeN tumor-bearing mice (n = 5 per group) and analyzed with the Student's t test or Mann-Whitney U test. All statistical tests were two-sided. We confirmed the basic principle using a caspase-sensitive nanoprobe (Apo-NP). Results: A single exposure of radiation was able to induce apoptosis in a small, defined region of the tumor, resulting in expression of caspase-3. Caspase-3 cleaved DEVD and activated the prodrug. The released free DOX further activated DEVD-S-DOX by exerting cytotoxic effects on neighboring tumor or supporting cells, which repetitively induced the expression of caspase-3 and the activation of DEVD-S-DOX. This sequential and repetitive process propagated the induction of apoptosis. This novel therapeutic strategy showed not only high efficacy in inhibiting tumor growth (14-day tumor volume [mm3] vs radiation alone: 848.21±143.24 vs 2511.50±441.89, P <. 01) but also low toxicity to normal cells and tissues. Conclusion: Such a phenotype induction strategy represents a conceptually novel approach to overcome tumor heterogeneity and complexity as well as to substantially improve current conventional chemoradiotherapy with fewer sequelae and side effects.

UR - http://www.scopus.com/inward/record.url?scp=84925546961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925546961&partnerID=8YFLogxK

U2 - 10.1093/jnci/dju403

DO - 10.1093/jnci/dju403

M3 - Article

VL - 107

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 2

M1 - dju403

ER -